New software-as-a-service solution provides customers with a single source for ePrint licensing, spend tracking, distribution and recipient-level data collection
Los Angeles, Calif., May 14, 2013– Reprints Desk, a wholly owned subsidiary of Research Solutions (RSSS), announced today the launch of a new compliance software-as-a-service (SaaS) solution for medical marketers. The solution simplifies Sunshine Act compliance related to the use of medical ePrints for sales, marketing and medical affairs.
Reprints Desk’s Sunshine ePrints solution records the delivery of each ePrint to the physician across publishers with a customizable ePrint registration page. Data collection includes HCP name, state and license number and unit-level ePrint cost. The solution is an extension of Reprints Desk’s reprint services including online ordering, publisher-licensing services, multichannel/multiplatform deployment including iPads and healthcare professional (HCP) portals.
The Physician Payment Sunshine Act, commonly referred to as the “Sunshine Act,” is regulation designed to provide transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or State Children's Health Insurance Program (SCHIP). Beginning August 1, 2013 onwards, all travel, gifts, meals, medical reprints and ePrints, honoraria and other items above $10 in value must be reported along with their itemized dates, values and the nature of each benefit. If total payments to a physician exceed $100 in a year, then all benefits to that physician must be reported. Companies out of compliance can be fined anywhere from $10,000 to $1,000,000.
“Pharmaceutical companies are scrambling to ensure that their use of scientific literature as an educational tool is fully compliant once the Sunshine Act reporting requirements take effect this summer,” said Scott Ahlberg, Head of Global Services at Reprints Desk. “While paper reprints are still a valuable leave behind during an HCP detail or at professional meetings, transitioning to ePrints can make it easier to comply with new industry regulations and Reprints Desk is the company that can help.”
Scholarly, peer-reviewed journal articles are important educational tools for healthcare professionals, helping them to understand new therapies and stay current on changing standards of care. Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. In June 2012, Reprints Desk launched the content-enriched website www.hcpengage.com, featuring video interviews with healthcare professionals and industry thought leaders on topics such as regulatory compliance, sales rep interactions, scientific literature usage, mobile usage and more.
For more information about Reprints Desk’s new ePrints compliance software-as-a-service (SaaS) solution, visit http://info.reprintsdesk.com/sunshine-act-compliance.
About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Organizations fueled by intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Reprints Desk is a wholly owned subsidiary of Research Solutions (RSSS) and has ranked #1 in the every Document Delivery Vendor Scorecard from industry analyst and advisory firm Outsell Inc. since 2008.
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.